You are here: Industry Insights > sclerosis

News List

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis worldpharmanews
September 17, 2019
Roche announced longer-term data from the Phase III open-label extension studies of OPERA I, OPERA II and ORATORIO showed that patients who were treated with OCREVUS® (ocrelizumab) continuously for ...
Serum Biomarker Linked to Brain Atrophy in Multiple Sclerosis drugs
September 12, 2019
Serum neurofilament light chain (sNFL) levels are significantly associated with clinical and neuroimaging outcomes in multiple sclerosis (MS), according to a study published online in JAMA Neurology.
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine worldpharmanews
September 06, 2019
Sandoz, a Novartis division and a global leader in biosimilars, announced that it has entered into a global commercialization agreement for a proposed natalizumab biosimilar.
Sandoz licences proposed multiple sclerosis biosimilar from Polpharma pharmaceutical-technology
September 04, 2019
Novartis unit Sandoz has signed an agreement with biopharmaceutical firm Polpharma Biologics for exclusive rights to commercialise a proposed biosimilar of Biogen’s multiple sclerosis drug natalizumab.
For Medicare Patients, Costs of MS Drugs Rise Sevenfold Over 10 Years drugs
August 30, 2019
Medicare patients with multiple sclerosis (MS) saw their medication costs soar by more than sevenfold over a decade, a new study finds.
Long-Term Night-Shift Work May Up Risk for Multiple Sclerosis drugs
August 29, 2019
A history of 20+ years of rotating night-shift work is associated with an increased risk for definite diagnosis of multiple sclerosis (MS)...
Regular Vaccines Advised With Multiple Sclerosis drugs
August 29, 2019
If you have multiple sclerosis (MS), you can and should receive recommended vaccinations -- including annual flu shots, a new American Academy of Neurology guideline says.
Guidelines Updated for Vaccination in Multiple Sclerosis drugs
August 29, 2019
Guidelines have been updated on vaccinations in patients with multiple sclerosis (MS); a practice guideline update summary was published online in Neurology.
Vaccination Does Not Up Risk for Developing Multiple Sclerosis drugs
August 07, 2019
Evidence shows that vaccination is not associated with an increased risk for being diagnosed with multiple sclerosis (MS) within the next five years, according to a study published online July 30 in Neurology.
FRAX Score Underestimates Risk for Fracture in Multiple Sclerosis drugs
July 22, 2019
FRAX Score Underestimates Risk for Fracture in Multiple Sclerosis.

Previous page 1 2 3 Next page